Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells $1,000,800.00 in Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Ryan Fukushima sold 20,000 shares of Tempus AI stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $50.04, for a total value of $1,000,800.00. Following the completion of the transaction, the chief executive officer owned 123,945 shares of the company’s stock, valued at approximately $6,202,207.80. This trade represents a 13.89% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ryan Fukushima also recently made the following trade(s):

• On Monday, August 3rd, Ryan Fukushima sold 23,818 shares of Tempus AI stock. The shares were sold at an average price of $46.19, for a total value of $1,100,153.42.
• On Wednesday, July 8th, Ryan Fukushima sold 33,284 shares of Tempus AI stock. The shares were sold at an average price of $57.39, for a total value of $1,910,168.76.
• On Monday, July 6th, Ryan Fukushima sold 10,000 shares of Tempus AI stock. The stock was sold at an average price of $60.00, for a total value of $600,000.00.
• On Tuesday, May 19th, Ryan Fukushima sold 13,550 shares of Tempus AI stock. The stock was sold at an average price of $44.07, for a total transaction of $597,148.50.

Tempus AI Trading Up 1.1%

TEM stock traded up $0.63 during mid-day trading on Tuesday, reaching $55.69. 3,770,004 shares of the stock traded hands, compared to its average volume of 5,831,829. The company has a debt-to-equity ratio of 3.06, a quick ratio of 3.16 and a current ratio of 3.30. Tempus AI, Inc. has a one year low of $40.77 and a one year high of $104.32. The stock has a market capitalization of $10.05 billion, a PE ratio of -38.67 and a beta of 3.58. The business has a 50-day moving average price of $51.37 and a two-hundred day moving average price of $51.74.

Tempus AI (NASDAQ:TEM) last released its earnings results on Thursday, July 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.10. Tempus AI had a negative net margin of 17.77% and a negative return on equity of 50.28%. The firm had revenue of $382.49 million during the quarter, compared to analyst estimates of $379.69 million. During the same quarter last year, the business earned ($0.22) EPS. The business’s revenue was up 21.6% on a year-over-year basis. Equities research analysts expect that Tempus AI, Inc. will post -1.38 EPS for the current year.

Analysts Set New Price Targets

Several analysts have issued reports on TEM shares. Wolfe Research initiated coverage on shares of Tempus AI in a research note on Tuesday, June 2nd. They issued a “peer perform” rating for the company. Piper Sandler cut their target price on Tempus AI from $58.00 to $56.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 4th. Lake Street Capital downgraded Tempus AI to a “hold” rating in a report on Monday, July 20th. Freedom Capital raised Tempus AI to a “hold” rating in a research note on Tuesday, June 30th. Finally, Wall Street Zen upgraded Tempus AI from a “sell” rating to a “hold” rating in a report on Saturday, July 25th. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $64.92.

Hedge Funds Weigh In On Tempus AI

Hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in shares of Tempus AI by 8.7% during the fourth quarter. Vanguard Group Inc. now owns 10,258,621 shares of the company’s stock valued at $605,772,000 after acquiring an additional 817,014 shares in the last quarter. ARK Investment Management LLC boosted its holdings in shares of Tempus AI by 5.3% in the fourth quarter. ARK Investment Management LLC now owns 7,557,583 shares of the company’s stock valued at $446,275,000 after purchasing an additional 381,816 shares during the period. GC Wealth Management RIA LLC bought a new position in Tempus AI in the fourth quarter worth approximately $399,267,000. Sumitomo Mitsui Trust Group Inc. increased its holdings in Tempus AI by 23.4% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,326,313 shares of the company’s stock worth $195,636,000 after purchasing an additional 821,490 shares during the period. Finally, Amova Asset Management Americas Inc. increased its holdings in Tempus AI by 23.4% during the 1st quarter. Amova Asset Management Americas Inc. now owns 4,326,313 shares of the company’s stock worth $195,549,000 after purchasing an additional 821,490 shares during the period. 24.22% of the stock is currently owned by institutional investors.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.